Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Look at BMI along with waist size, activity level, and body composition when possible [22]
An analysis of the ELIXA trial data indicated that short-term GLP-1RAs may also have renal protective effects, analogous to long-acting GLP-1RAs [47]
A clinical trial found that tesofensine increased satiety, sense of fullness, and 24-h fat oxidation (fat burning) in overweight and obese individuals
The HTR4 antagonist GR113808 reduced HFD-induced body weight gain and improved glucose and triglyceride metabolism To examine the role of HTR4 in body weight gain and fat accumulation in the liver, mice were fed an HFD and injected with GR113808, an HTR4 antagonist, for 12 weeks
Beyond statistical significance on isolated endpoints, findings from this umbrella review indicate a shift in the management of metabolic diseases from single-metric control to an integrated, multi-organ and multi-risk-factor strategy
US$ 20.77
US$ 22.48
US$ 26.49
US$ 20.09
US$ 23.96
US$ 25.55
US$ 26.13
US$ 24.36
US$ 27.61
